Safety and Efficacy of AGN208397 in the Treatment of Macular Edema Associated With Retinal Vein Occlusion (RVO)

NCT01027650 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

121

Enrollment

INDUSTRY

Sponsor class

Conditions

Macular Edema
Retinal Vein Occlusion

Interventions

DRUG: AGN208397 intravitreal injection
DRUG: dexamethasone intravitreal implant

Sponsor

Allergan